A phase 3 study of safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine, in children with HIV
一项针对HIV感染儿童的3期临床试验，旨在评估V114（一种15价肺炎球菌结合疫苗）与23价肺炎球菌多糖疫苗联合接种的安全性和免疫原性。
期刊:AIDS
影响因子:3.1
doi:10.1097/QAD.0000000000003551
Wilck, Marissa; Barnabas, Shaun; Chokephaibulkit, Kulkanya; Violari, Avy; Kosalaraksa, Pope; Yesypenko, Svitlana; Chukhalova, Iryna; Dagan, Ron; Richmond, Peter; Mikviman, Elena; Morgan, Leslie; Feemster, Kristen; Lupinacci, Robert; Chiarappa, Joseph; Madhi, Shabir A; Bickham, Kara; Musey, Luwy
